Select Page

Home / Share Price Target / Auropharma

Aurobindo Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts

Aurobindo Pharma Limited

Company LogoSymbol: AUROPHARMA
Price: ₹1,213.05
Exchange: NSE
Healthcare -> Drug Manufacturers—Specialty & Generic
Show Table of Contents

Aurobindo Pharma Brief Company Overview

Aurobindo Pharma Limited: A Leading Pharmaceutical Company

  • Key Products and Services: Generic formulations, active pharmaceutical ingredients (API), antiretroviral drugs, biocatalysts, and contract services covering the entire drug lifecycle
  • History and Market Presence: Founded in 1986, headquartered in Hyderabad, India; operates in India, the US, Europe, and internationally
  • Reputation: Renowned in the industry for its diverse product range and commitment to quality
  • Commitment: Dedicated to providing affordable and accessible healthcare solutions

Advertisement

Aurobindo Pharma Financial Performance

MetricValueDescription
Market Capital71,320.52 CroreMarket valuation of Aurobindo Pharma's shares.
Revenue (TTM)29,001.86 CroreTotal revenue generated by Aurobindo Pharma over the past twelve months.
Net Income (TTM)+3,172.97 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin17.58%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin10.94%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+17.1%Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+79.5%Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
22.27Company's total debt divided by total shareholder equity.
Total Debt6,647.62 CroreSum of Aurobindo Pharma's current & long-term financial obligations.
Total Cash6,328.87 CroreTotal amount of liquid funds available to Aurobindo Pharma.
Beta0.51Beta is less than 1 indicating that the Aurobindo Pharma's price is less volatile than the market.

Is Aurobindo Pharma A Good Buy For Long Term?

Aurobindo Pharma, a large-cap stock with a robust market capitalization of 71,320.52 Crore, demonstrates strong financial performance. With a 10.94% profit margin and impressive revenue growth of 17.1% in the previous quarter, the company has generated a net profit of 3,172.97 Crore in the last 12 months. While its debt position is notable at 6,647.62 Crore, a healthy cash balance of 6,328.87 Crore provides a cushion. The stock's consistent return history, including 64.20% over the past year and 65.95% over the past five years, suggests strong potential for long-term growth, making it an attractive buy for investors seeking to add a reliable pharmaceutical player to their portfolio.

To predict the Aurobindo Pharma's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Aurobindo Pharma Share Price Target For 2024

 Aurobindo Pharma Targets For 2024 Chart

The line chart displays the monthly closing prices of Aurobindo Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Aurobindo Pharma shares in 2024, see the table below.

Advertisement

Aurobindo Pharma Share Price Target Table For 2024

Aurobindo Pharma's LevelsValueReason/Importance
2024 Target 31277.65 (+5.32%)Price Action: 10 Jun 2024 High
2024 Target 21264.65 (+4.25%)Price Action: 14 Jun 2024 High
2024 Target 11251.50 (+3.16%)Price Action: 07 Jun 2024 Low
Current Price1213.05 Aurobindo Pharma's 1 share price as of Tue 02 Jul 2024
Stop Loss 11197.25 (-1.31%)Price Action: 05 Jun 2024 Low
Stop Loss 21180.09 (-2.72%)Price Action: 27 Jun 2024 Low
Stop Loss 31162.65 (-4.16%)Price Action: May 2024 Low

Summary: Aurobindo Pharma Share Price Prediction For 2024

In summary, Aurobindo Pharma has surged by ₹129.05, achieving a notable +11.90% increase from 1st January 2024 to 02 Jul 2024. Our analysis of Aurobindo Pharma for 2024 predicts an additional rise of 3.16% to 5.32% by the end of 2024 with three potential targets T1: 1251.50, T2: 1264.65, T3: 1277.65. Stop Loss at SL1: 1197.25, SL2: 1180.09, SL3: 1162.65.

Aurobindo Pharma has a 52-week high of ₹1292.09, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹708.84, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Aurobindo Pharma.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Aurobindo Pharma Share Price Target For 2025

 Aurobindo Pharma Targets For 2025 Chart

The line chart displays the monthly closing prices of Aurobindo Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Aurobindo Pharma shares in 2025, see the table below.

Advertisement

Aurobindo Pharma Share Price Target Table For 2025

Aurobindo Pharma's LevelsValueReason/Importance
2025 Target 31778.24 (+46.59%)Fibonacci Extension Level 171.8%
2025 Target 21736.95 (+43.18%)Price Action: Chart
2025 Target 11719.75 (+41.77%)Custom Fibonacci Extension Lvl 64.9%
Current Price1213.05 Aurobindo Pharma's 1 share price as of Tue 02 Jul 2024
Stop Loss 11099.90 (-9.33%)Price Action: Dec 2023 High
Stop Loss 21088.90 (-10.24%)Price Action: Chart
Stop Loss 31063.75 (-12.31%)Price Action: May 2021 High

Summary: Aurobindo Pharma Share Price Prediction For 2025

In summary, Aurobindo Pharma has surged by ₹129.05, achieving a notable +11.90% increase from 1st January 2024 to 02 Jul 2024. Our analysis of Aurobindo Pharma for 2025 predicts an additional rise of 41.77% to 46.59% by the end of 2025 with three potential targets T1: 1719.75, T2: 1736.95, T3: 1778.24. Stop Loss at SL1: 1099.90, SL2: 1088.90, SL3: 1063.75.

Aurobindo Pharma has a All-Time high of ₹1292.09, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹708.84, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Aurobindo Pharma, we have created a specific page for that check here: Aurobindo Pharma Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Aurobindo Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039

 Aurobindo Pharma Targets Chart 2024, 2025, 2026 to 2039

This chart presents a detailed projection of Aurobindo Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.41% over the next 15 years.

For complete year by year Aurobindo Pharma long term share price target from 2024, 2025 to 2039 check the below table.

Aurobindo Pharma Share Price Target Table From 2024, 2025, 2026 to 2039

Year Aurobindo Pharma TargetYoY Change %
2024₹1,213.05[Current Price]
2024₹1,847.352.28%
2025₹2,455.0832.9%
2026₹2,888.2617.64%
2027₹3,485.4320.67%
2028₹4,660.5233.71%
2029₹5,416.8716.22%
2030₹5,876.738.48%
2031₹6,036.172.71%
2032₹6,604.349.41%
2033₹8,197.8924.12%
2034₹8,986.449.61%
2035₹9,298.373.47%
2036₹9,184.09-1.23%
2037₹9,723.255.87%
2038₹11,735.2520.69%
2039₹10,758.05-8.33%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Aurobindo Pharma Past Performance

AUROPHARMA main
Aurobindo Pharma has been listed on NSE for more than 29 years.
  • In 1995, Aurobindo Pharma opening price was ₹2.06
  • As of Tue 02 Jul 2024 the price stands at ₹1,213.05.
  • This represents a Compound Annual Growth Rate (CAGR) of 23.69%.
  • In 29 years, an investment of 10,000 would have become ₹58.88 Lakh.

As we wrap up, we hope you like our study on Aurobindo Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Aurobindo Pharma Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter